SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

EKSO is experiencing significant upward momentum and trading volume following the announcement of a proposed business combination with Applied Digital's cloud division, forming a new AI compute platform, ChronoScale. The community is actively discussing this pivot into AI infrastructure, with many anticipating a substantial short squeeze despite lingering concerns about potential dilution. This move highlights EKSO's transformation into a key player in the rapidly expanding AI sector.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo (OKLO) is a major topic of discussion as investors eagerly await a potential Department of Energy plutonium award, expected by year-end, seen as a crucial catalyst for its advanced nuclear reactor development. The community is sharply divided between concerns over recent insider selling and dilution, and optimism driven by institutional accumulation at support levels, short squeeze potential, and its role in powering the AI energy sector. This highly anticipated news follows the company's recent initial safety approval for its Aurora fuel fabrication facility.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies is trending amidst strong anticipation of easing Federal Reserve policy and falling interest rates, expected to drive a significant refinancing wave and broader housing market recovery. The community is largely bullish, noting strong technical indicators and heavy call option activity as signals of institutional accumulation and a potential breakout. Discussions highlight RKT's strategic advantage as a vertically integrated fintech and mortgage platform, leveraging recent acquisitions and AI for future growth across the housing ecosystem.

BUUU Group Ltd. is a holding company, which operates through its subsidiaries, BU Creation and BU Workshop. Its subsidiaries engage in design, planning and production of face-to-face events, immersive environments and brand-based experiences for clients and venues, including event organizers, consumer brand marketers and retail shopping centers. The company was founded in 2017 and is headquartered in Hong Kong.

BUUU Group Ltd. - Ordinary Shares - Class A

BUUU Group Ltd

BUUU Group Ltd is experiencing extreme price volatility and multiple trading halts, drawing significant attention as a low-float China/Hong Kong stock. The community is sharply divided, with some actively speculating on a potential parabolic surge, drawing comparisons to past high-flying meme stocks. Conversely, many caution that its rapid movements signal a high-risk pump and dump scheme, emphasizing its purely speculative nature.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending, fueled by an exceptionally active and dedicated community passionately championing the "OG meme" narrative of Rage Comics. This committed base is consistently building out an ecosystem with projects like RageMaker and RageGames, aiming to onboard new users into crypto. The community expresses strong conviction, viewing RAGE as significantly undervalued and poised for substantial long-term growth within the broader market upswing as they lead a "return to the memes."

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

PSKY is trending as its amended all-cash offer for Warner Bros. Discovery, now backed by Larry Ellison's personal guarantee, intensifies the high-stakes acquisition battle. The community is actively debating the WBD board's decision to favor Netflix's competing proposal, questioning whether it aligns with shareholder value and fiduciary duties amidst concerns over deal terms and regulatory hurdles.

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

BYTE Crypto is trending with its highly engaged community championing it as 'Grok's AI dog' and 'the chosen one,' drawing strong ties to Elon Musk's AI narrative. Enthusiasts are actively encouraging others to 'byte the dip' and 'hold the line,' fueled by widespread anticipation of major developments. The community firmly believes BYTE is poised to be the future of AI in the crypto space.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending due to its vibrant ecosystem bustling with memecoin activity, with tokens like $RAGE and $COCK driving significant community conversation. While some express strong conviction in its high-speed blockchain and long-term potential, others are debating its price stability amid perceived short-term volatility. The broader discussion centers on Solana's role as a platform for innovation and its position within the evolving crypto landscape.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics ($CORT) is seeing intense trading activity driven by recent positive Phase 3 data for relacorilant in platinum-resistant ovarian cancer and an upcoming PDUFA decision for Cushing's syndrome, further buoyed by promising long-term survival data from its ALS program. The community is actively debating the stock's significant short interest and the potential for a massive short squeeze, with many viewing current price levels as an attractive buying opportunity given the projected multi-billion-dollar revenue potential from its robust pipeline.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending with high anticipation for multiple imminent FDA decisions, including a PDUFA date for its motion sickness drug, Tradipitant, and an expedited re-review for Hetlioz in jet lag. The community is actively discussing Tradipitant's significant potential in addressing GLP-1 induced nausea, viewing these regulatory catalysts as crucial for a re-rating given the company's improved relationship with the FDA. Investors are keenly watching for outcomes that could lead to considerable stock movement, drawing comparisons to other recent biotech approvals.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million

Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million PR...

Compugen (NASDAQ:CGEN) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded Compugen from a "sell" rating to a "hold" rating in a research report on Saturday...

Analysts Set Expectations for Compugen FY2025 Earnings

Compugen Ltd. (NASDAQ:CGEN - Free Report) - Equities researchers at Leerink Partnrs increased their FY2025 earnings per share estimates for Compugen in a research report issued on Monday, November...

FY2025 EPS Estimates for Compugen Lifted by Leerink Partnrs

Compugen Ltd. (NASDAQ:CGEN - Free Report) - Investment analysts at Leerink Partnrs raised their FY2025 earnings per share estimates for shares of Compugen in a research note issued on Monday...

Compugen (NASDAQ:CGEN) Issues Quarterly Earnings Results

Compugen (NASDAQ:CGEN - Get Free Report) released its quarterly earnings results on Monday. The biotechnology company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts...

Compugen (CGEN) Reports Q3 Loss, Lags Revenue Estimates

Compugen (CGEN) delivered earnings and revenue surprises of +22.22% and -14.43%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Certara, Inc. (CERT) Q3 Earnings Surpass Estimates

Certara (CERT) delivered earnings and revenue surprises of +27.27% and -0.57%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Compugen to Participate in Stifel 2025 Healthcare Conference

Compugen to Participate in Stifel 2025 Healthcare Conference Compugen to Participate in Stifel 2025 Healthcare Conference PR Newswire HOLON, Israel, Nov. 4, 2025 HOLON, Israel, Nov. 4, 2025...

Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Top Estimates

Vertex (VRTX) delivered earnings and revenue surprises of +5.49% and +1.14%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025

Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025 Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025 PR Newswire HOLON, Israel, Oct. 27, 2025 HOLON...

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.

CGEN
Compugen Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CGEN News

CGENCompugen Ltd